C-terminal Src kinase | 928308-20-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: C-terminal Src kinase
• 英文别名: CSK；8-(2-dimethylaminoethoxy)-2-(4-phenoxyphenyl)-6,11-dihydro-5H-pyrazolo[5,1-b][1,3]benzodiazepine-1-carboxamide；TKM0150；8-[2-(dimethylamino)ethoxy]-2-(4-phenoxyphenyl)-6,11-dihydro-5H-pyrazolo[5,1-b][1,3]benzodiazepine-1-carboxamide
• CAS: 928308-20-7
• 化学式: C₂₈H₂₉N₅O₃
• 分子量: 483.57
• InChiKey: SYWUIAOLWMUYTP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  36
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  94.6
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  7-hydroxy-2-(4-phenoxyphenyl)-9,10-dihydro-4H-benzo[d]pyrazolo[1,5-a][1,3]diazepine-3-carboxamide 、 alkaline earth salt of/the/ methylsulfuric acid 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 C-terminal Src kinase
  参考文献：
  名称：

  Ring-fused pyrazole derivatives as potent inhibitors of lymphocyte-specific kinase (Lck): Structure, synthesis, and SAR

  摘要：

  We have identified a novel series of ring-fused pyrazole derivatives as lymphocyte-specific kinase (Lck) inhibitors. The most potent analogs exhibited good enzyme inhibitory activity (IC(50)s <1 nM) as well as excellent cellular activity against mixed lymphocyte reaction (MLR) (IC(50)s <1 nM). (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.11.013

文献信息

• Ring-fused pyrazole derivatives as potent inhibitors of lymphocyte-specific kinase (Lck): Structure, synthesis, and SAR
  作者：Tetsuo Takayama、Hiroki Umemiya、Hideaki Amada、Tetsuya Yabuuchi、Takeshi Koami、Fumiyasu Shiozawa、Yusuke Oka、Akiko Takaoka、Akie Yamaguchi、Mayumi Endo、Masakazu Sato

  DOI：10.1016/j.bmcl.2009.11.013

  日期：2010.1

  We have identified a novel series of ring-fused pyrazole derivatives as lymphocyte-specific kinase (Lck) inhibitors. The most potent analogs exhibited good enzyme inhibitory activity (IC(50)s <1 nM) as well as excellent cellular activity against mixed lymphocyte reaction (MLR) (IC(50)s <1 nM). (C) 2009 Elsevier Ltd. All rights reserved.